You just read:

NX Prenatal Announces Key Clinical Validation Trial of its Exosome-Based Blood Test for Preterm Birth Risk in Collaboration with Indiana University School of Medicine

News provided by

NX Prenatal Inc.

Oct 24, 2018, 14:11 ET